The VA Dental Checkbox That Follows Veterans Everywhere

Photo by Navy Medicine via Unsplash.

A veteran sits in a VA dental clinic, fills out the standard intake form, and comes to a box asking about marijuana use. It seems like a routine health history question, the kind you'd answer honestly at any dentist's office. But that checkbox doesn't stay in the dental file. It becomes a permanent entry in the veteran's shared VA electronic health record, visible to every VA provider who treats that person going forward, from primary care to pain management to mental health services.

This isn't an accident or a paperwork glitch. It's how VHA Directive 1315 is designed to work. Issued December 8, 2017 and still the governing policy as of April 2026, the directive requires VA clinicians to document cannabis use for treatment planning purposes. It also explicitly protects veterans from having that disclosure affect their benefits eligibility or access to VA care. That's a real and meaningful protection. But it's only half the picture.

Here's the tension nobody spells out on the intake form: veterans have a legal right to disclose cannabis use without being penalized for it, but they have no corresponding right to control what happens to that information once it's in the chart. It can shape prescribing decisions, flag them for extra scrutiny, and follow them across specialties, and there's no process to contest, contextualize, or remove it. That gap matters right now more than usual, with the Veterans Equal Access Act stalled in Congress again and a DEA rescheduling hearing running through mid-July 2026 that most veterans assume will fix this. It won't.

What Actually Happens When You Check That Box

Photo by Andrea Piacquadio via Pexels.

When a veteran checks that cannabis-use box, VA staff aren't just noting it for the dentist's reference. Directive 1315 requires the information to be recorded in the veteran's actual VA medical record, and it typically lands in the 'non-VA/herbal/OTC medication' section of the chart. That section isn't siloed by department. A dental hygienist's notes, a primary care physician's intake, a mental health screening -- they all feed into the same longitudinal record, and that non-VA medication section is visible to any VA clinician pulling up the chart, regardless of what brought the veteran in that day.

The record itself is treated as confidential medical information under standard patient privacy and confidentiality protections. But 'confidential' in this context means it's shielded from outside parties, not that it's invisible within the VA system. A pain management provider reviewing a veteran's chart six months later, with no memory of the dental visit and no direct conversation with the veteran about it, will still see that cannabis-use notation sitting alongside other medications and habits.

That single data point doesn't just sit there passively. VA clinical practice often treats documented cannabis use as a factor in decisions like opioid co-prescribing, where providers may exercise added caution or request additional monitoring based on what's in the chart. These are judgment calls made by whichever provider is treating the veteran at that moment, often without circling back to ask the veteran anything further about the original disclosure.

The disconnect is that most veterans checking a box on dental paperwork have no idea they're feeding a system-wide record. They think they're answering a dentist's question about their own oral health history. Nobody hands them a plain-language explanation that this single checkbox becomes a permanent, cross-specialty chart entry the moment they submit the form.

The Legal Guardrails -- And Their Limits

Photo by Remington Wigzell via Unsplash.

Directive 1315 does get one thing unambiguously right: it states that participation in a state marijuana program cannot affect a veteran's eligibility for VA care or benefits. That's not a vague policy preference, it's an explicit protection written into the directive itself, and it means a veteran who discloses cannabis use isn't at risk of losing access to VA health services or disability compensation because of that disclosure.

But the same directive draws hard lines around what VA clinicians can actually do with that information. VA providers cannot sign paperwork for state medical marijuana programs. They cannot recommend medical marijuana to a patient, even in a state where it's fully legal and regulated. They're limited to prescribing FDA-approved medications, full stop. Since most THC and CBD products on the market today still lack FDA approval, VA pharmacies won't fill or supply them, no matter what a veteran's home state allows.

So the protection covers eligibility, but it doesn't cover influence. That's the gap. The same chart entry that legally can't touch a veteran's benefits can still shape how a provider approaches prescribing, monitoring, or clinical caution, and there's no formal appeal process for a veteran who thinks that influence was applied unfairly or based on incomplete context.

What this produces is a one-way street. Veterans are legally safe to disclose cannabis use honestly. But once it's written down, there's no mechanism to go back and correct an outdated entry, add context about why they used it, or have it removed if it's no longer relevant to their care. The system asks for honesty and doesn't return control.

Why Congress Hasn't Fixed the Underlying Problem

Photo by Karson via Unsplash.

Congress has actually tried to close this gap, repeatedly. The Veterans Equal Access Act would let VA doctors formally discuss medical marijuana with patients and issue recommendations in states where it's legal, which would finally give VA clinicians authority that matches what veterans are already allowed to disclose. It's not a radical proposal. It would bring VA practice in line with how millions of other patients already interact with their doctors in medical marijuana states.

The bill's track record is telling. It has passed as an amendment to Military Construction and Veterans Affairs appropriations bills in both the House and Senate on multiple occasions. Most recently, the House passed it again on June 25, 2025, by a vote of 218-206. That's not a fringe measure struggling for support, it's cleared floor votes with real margins more than once.

And yet it has never become law. Every time, the provision gets stripped out during conference negotiations between the House and Senate before the final appropriations package is signed. The pattern repeats: pass it, negotiate it away, move on to the next budget cycle without it.

The practical result is that the restrictive posture baked into Directive 1315 remains fully intact today, unchanged by years of legislative near-misses. No VA form-signing for state programs, no recommendations from VA doctors, no pharmacy fills for cannabis products, regardless of state law. Veterans are stuck in the same bind year after year: a full legal duty to disclose their use honestly, paired with zero corresponding authority granted to the very providers treating them. Congress keeps voting to fix it and keeps letting it slip away in negotiations.

The DEA Rescheduling Hearing Won't Change This -- Yet

Photo by Héctor Berganza via Pexels.

There's a lot of understandable optimism among veterans right now that federal rescheduling will finally sort this out. It won't, at least not on its own. On December 18, 2025, President Trump signed an executive order directing the Attorney General to expedite rulemaking on moving marijuana from Schedule I to Schedule III. Acting Attorney General Todd Blanche followed with an order on April 24, 2026 that immediately placed FDA-approved marijuana products and state-licensed medical marijuana into Schedule III, while setting up a broader rescheduling hearing to work through the rest.

That hearing began June 29, 2026 at 9 a.m. ET and is scheduled to conclude no later than July 15, 2026, with a planned recess from July 3 to July 6 around the Independence Day holiday. It's a real, substantive proceeding, but it's also a narrow one.

Recreational marijuana and any non-FDA-approved, non-state-licensed products remain Schedule I under the current framework. This process does not legalize marijuana federally, and it isn't structured to do so. It's a scheduling adjustment for a specific carved-out category of products, not a wholesale change to federal marijuana law.

Even in the best-case outcome, where the hearing concludes with broader rescheduling changes, VA's internal directive and the restrictions on VA clinicians wouldn't shift automatically. VA policy is set by VA, through its own directive process, separate from DEA scheduling decisions. Directive 1315 would still need its own update, through its own channels, regardless of what the DEA decides by mid-July. Veterans hoping rescheduling alone will let their VA doctor start recommending cannabis are going to be disappointed.

None of this requires a complicated fix. Congress already has a bill that would close the gap: pass the Veterans Equal Access Act, give VA clinicians the authority to discuss and recommend medical marijuana that matches what veterans are already legally permitted to disclose, and stop stripping the provision out in conference every single cycle. The votes have been there in both chambers more than once. What's missing is follow-through.

Until that changes, veterans need to go into any VA appointment, dental or otherwise, understanding exactly what they're signing up for. Any cannabis disclosure on any VA form becomes a permanent, system-wide chart entry the moment it's submitted. It can't be edited, contextualized after the fact, or withdrawn, even though it legally can't touch benefits or eligibility for care.

That's not a reason to lie on intake paperwork, and this isn't legal advice telling you to withhold information from your provider. It's a reason to know the stakes before you check the box. Confirm your own state's medical marijuana laws, since they vary considerably and keep shifting as more states adjust their programs. Then have an actual conversation with your VA provider about what a disclosure means for your specific chart, your specific treatment plan, and your specific specialties of care. The honesty requirement is on you. The transparency about consequences should be on the system, and right now, it isn't.